Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Eton Pharmaceuticals, Inc. (ETON) shares soared 6.7% in the last trading session to close at $23.81. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 24.5% gain over the past four weeks.Eton Pharmaceuticals’ stock price gain can be attributed to the latest FDA approval for Desmoda (desmopressin acetate) oral solution for the management of central diabetes insipidus (arginine vasopressin deficiency) across all age groups. In additi ...